References
- Akiskal HS, Benazzi F. Family history validation of the bipolar nature of depressive mixed states. J Affect Disord 2003;73:113-122. https://doi.org/10.1016/S0165-0327(02)00330-0
- Akiskal HS, Benazzi F. Validating Kraepelin's two types of depressive mixed states: “depression with flight of ideas“and” excited depression”. World J Biol Psychiatry 2004;5:107-113. https://doi.org/10.1080/15622970410029919
- Benazzi F. Depressive mixed states: unipolar and bipolar II. Eur Arch Psychiatry Clin Neurosci 2000;250:249-253. https://doi.org/10.1007/s004060070014
- Benazzi F. Depressive mixed state: testing different definitions. Psychiatry Clin Neurosci 2001;55:647-652. https://doi.org/10.1046/j.1440-1819.2001.00919.x
- Benazzi F. Mixed states in bipolar II disorder: should full hypomania always be required? Psychiatry Res 2004;127:247-257. https://doi.org/10.1016/j.psychres.2003.07.006
- Benazzi F, Akiskal HS. Delineating bipolar II mixed states in the Ravenna-San Diego collaborative study: the relative prevalence and diagnostic significance of hypomanic features during major depressive episodes. J Affect Disord 2001;67:115-122. https://doi.org/10.1016/S0165-0327(01)00444-X
- Shim IH, Woo YS, Jun TY, Bahk WM. Mixed-state bipolar I and II depression: time to remission and clinical characteristics. J Affect Disord 2014;152-154:340-346. https://doi.org/10.1016/j.jad.2013.09.035
- Muneer A. Staging models in bipolar disorder: a systematic review of the literature. Clin Psychopharmacol Neurosci 2016;14:117-130. https://doi.org/10.9758/cpn.2016.14.2.117
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed, text revision. Wasington, DC:American Psychiatric Association;2000.
- Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 2009;6:e1000100. https://doi.org/10.1371/journal.pmed.1000100
- Suppes T, Silva R, Cucchiaro J, Mao Y, Targum S, Streicher C, et al. Lurasidone for the treatment of major depressive disorder with mixed features: a randomized, double-blind, placebo-controlled study. Am J Psychiatry 2016;173:400-407. https://doi.org/10.1176/appi.ajp.2015.15060770
- Tsai J, Thase ME, Mao Y, Ng-Mak D, Pikalov A, Loebel A. Lurasidone for major depressive disorder with mixed features and anxiety: a post-hoc analysis of a randomized, placebo-controlled study. CNS Spectr 2017;22:236-245. https://doi.org/10.1017/S1092852917000074
- Swann AC, Fava M, Tsai J, Mao Y, Pikalov A, Loebel A. Lurasidone for major depressive disorder with mixed features and irritability: a post-hoc analysis. CNS Spectr 2017;22:228-235. https://doi.org/10.1017/S1092852917000232
- Sramek J, Loebel A, Murphy M, Mao Y, Pikalov A, Cutler NR. Lurasidone in post-menopausal females with major depressive disorder with mixed features: post-hoc analysis of a placebo-controlled trial. Prog Neuropsychopharmacol Biol Psychiatry 2017;78:12-17. https://doi.org/10.1016/j.pnpbp.2017.05.002
- Goldberg J, Mao Y, Siu C, Tsai J, Pikalov A, Calabrese J, et al. Lurasidone for the treatment of major depressive disorder with mixed features: do manic symptoms moderate treatment response? Neuropsychopharmacology 2016;41:S515-S516.
- Patkar AA, Pae CU, Vohringer PA, Mauer S, Narasimhan M, Dalley S, et al. A 13-week, randomized double-blind, placebo-controlled, cross-over trial of ziprasidone in bipolar spectrum disorder. J Clin Psychopharmacol 2015;35:319-323. https://doi.org/10.1097/JCP.0000000000000323
- Suppes T, Ostacher M. Mixed features in major depressive disorder: diagnoses and treatments. CNS Spectr 2017;22:155-160. https://doi.org/10.1017/S1092852917000256
- Benazzi F, Berk M, Frye MA, Wang W, Barraco A, Tohen M. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis. J Clin Psychiatry 2009;70:1424-1431. https://doi.org/10.4088/JCP.08m04772gre
- Tohen M, Kanba S, McIntyre RS, Fujikoshi S, Katagiri H. Efficacy of olanzapine monotherapy in the treatment of bipolar depression with mixed features. J Affect Disord 2014;164:57-62. https://doi.org/10.1016/j.jad.2014.04.003
- McIntyre RS, Cucchiaro J, Pikalov A, Kroger H, Loebel A. Lurasidone in the treatment of bipolar depression with mixed (subsyndromal hypomanic) features: post hoc analysis of a randomized placebo-controlled trial. J Clin Psychiatry 2015;76:398-405. https://doi.org/10.4088/JCP.14m09410
- Patkar A, Gilmer W, Pae CU, Vohringer PA, Ziffra M, Pirok E, et al. A 6 week randomized double-blind placebo-controlled trial of ziprasidone for the acute depressive mixed state. PLoS One 2012;7:e34757. https://doi.org/10.1371/journal.pone.0034757
- Pae CU, Patkar AA, Gilmer W, Holtzman N, Thommi SB, Ghaemi SN. Predictors of response to ziprasidone: results from a 6-week randomized double-blind, placebo-controlled trial for acute depressive mixed state. Pharmacopsychiatry 2012;45:152-155. https://doi.org/10.1055/s-0031-1297984
- Muralidharan K, Ali M, Silveira LE, Bond DJ, Fountoulakis KN, Lam RW, et al. Efficacy of second generation antipsychotics in treating acute mixed episodes in bipolar disorder: a meta-analysis of placebo-controlled trials. J Affect Disord 2013;150:408-414. https://doi.org/10.1016/j.jad.2013.04.032
- Nelson C, Tsai J, Mao Y, Pikalov A, Loebel A. Lurasidone for major depressive disorder with mixed features: effect of baseline depression severity on clinical outcome. Eur Neuropsychopharmacol 2016;26(Suppl):S400-S401. https://doi.org/10.1016/S0924-977X(16)31360-8
- Pikalov A, Goldberg J, Mao Y, Siu C, Tsai J, Calabrese J, et al. Lurasidone for the treatment of major depressive disorder with mixed features: do manic symptoms moderate treatment response? Eur Psychiatry 2017;41 Suppl:S243.
- Stahl SM, Morrissette DA, Faedda G, Fava M, Goldberg JF, Keck PE, et al. Guidelines for the recognition and management of mixed depression. CNS Spectr 2017;22:203-219. https://doi.org/10.1017/S1092852917000165
- Pae CU, Vohringer PA, Holtzman NS, Thommi SB, Patkar A, Gilmer W, et al. Mixed depression: a study of its phenomenology and relation to treatment response. J Affect Disord 2012;136:1059-1061. https://doi.org/10.1016/j.jad.2011.11.024
- Seo JS, Bahk WM, Wang HR, Woo YS, Park YM, Jeong JH, et al. Korean Medication Algorithm for Depressive Disorders 2017: third revision. Clin Psychopharmacol Neurosci 2018;16:67-87. https://doi.org/10.9758/cpn.2018.16.1.67
- Wang HR, Bahk WM, Seo JS, Woo YS, Park YM, Jeong JH, et al. Korean medication algorithm for depressive disorder: comparisons with other treatment guidelines. Clin Psychopharmacol Neurosci 2017;15:199-209. https://doi.org/10.9758/cpn.2017.15.3.199
- McIntyre RS, Suppes T, Tandon R, Ostacher M. Florida best practice psychotherapeutic medication guidelines for adults with major depressive disorder. J Clin Psychiatry 2017;78:703-713. https://doi.org/10.4088/JCP.16cs10885
- Houston JP, Tohen M, Degenhardt EK, Jamal HH, Liu LL, Ketter TA. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study. J Clin Psychiatry 2009;70:1540-1547. https://doi.org/10.4088/JCP.08m04895yel
Cited by
- Diagnostic Issues of Depressive Disorders from Kraepelinian Dualism to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition vol.16, pp.9, 2018, https://doi.org/10.30773/pi.2019.09.07
- Depression Preceding Diagnosis of Bipolar Disorder vol.11, pp.None, 2018, https://doi.org/10.3389/fpsyt.2020.00500
- The Korean Medication Algorithm Project for Bipolar Disorder (KMAP‐BP): Changes in preferred treatment strategies and medications over 16 years and five editions vol.22, pp.5, 2018, https://doi.org/10.1111/bdi.12902
- Current Limitations and Candidate Potential of 5-HT7 Receptor Antagonism in Psychiatric Pharmacotherapy vol.12, pp.None, 2018, https://doi.org/10.3389/fpsyt.2021.623684
- Electroconvulsive Therapy in Mania: A Review of 80 Years of Clinical Experience vol.178, pp.3, 2018, https://doi.org/10.1176/appi.ajp.2020.20030238
- Diagnosing and treating major depressive episodes that lie along the mood disorders spectrum: focus on depression with mixed features vol.26, pp.2, 2018, https://doi.org/10.1017/s1092852921000262
- Ecological momentary assessment of mood and movement with bipolar disorder over time: Participant recruitment and efficacy of study methods vol.30, pp.4, 2018, https://doi.org/10.1002/mpr.1895